Correlation Between Pmv Pharmaceuticals and Covalon Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Covalon Technologies, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Covalon Technologies.

Diversification Opportunities for Pmv Pharmaceuticals and Covalon Technologies

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pmv and Covalon is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Covalon Technologies go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Covalon Technologies

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 2.31 times less return on investment than Covalon Technologies. But when comparing it to its historical volatility, Pmv Pharmaceuticals is 1.46 times less risky than Covalon Technologies. It trades about 0.07 of its potential returns per unit of risk. Covalon Technologies is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  247.00  in Covalon Technologies on September 4, 2024 and sell it today you would earn a total of  18.00  from holding Covalon Technologies or generate 7.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Covalon Technologies

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Covalon Technologies 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Covalon Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Covalon Technologies reported solid returns over the last few months and may actually be approaching a breakup point.

Pmv Pharmaceuticals and Covalon Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Covalon Technologies

The main advantage of trading using opposite Pmv Pharmaceuticals and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.
The idea behind Pmv Pharmaceuticals and Covalon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device